Etid klinik pou Atak kè nan Michigan
6 etid pou Atak kè ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Paragon Health, Inc, Kalamazoo
- Michigan Kidney Consultants, PC, Pontiac
- St. Clair Nephrology Research, Roseville
- ak 1 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Henry Ford Hospital, Detroit
- AA Medical Research Center, Flint
- Metro Health Univ of MI Health, Wyoming
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Henry Ford Health System, Detroit
- Healthy Heart Cardiology, Grand Rapids
- MyMichigan Medical Center Midland - Clinical Research Department, Midland
- ak 2 plis
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Henry Ford Hospital, Detroit
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Henry Ford Health System, Detroit
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04774159Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Midland
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 27, 2026 · NCT06927739Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.